Rubin Steven D — SEC Form 4 filings

SEC reporting owner CIK 1381874. 21 Form 4 filings on record with FilingPulse; latest filed 2026-08-07.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2024-01-05 to 2026-08-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Red Violet, Inc. (RDVT)Director41 leg · 10,000 sh · $389,3003
Entera Bio Ltd.Director32 legs · 15,000 sh · $19,4503
OPKO HEALTH, INC. (OPK)Executive VP-Administration, Director41 leg · 10,000 sh · $8,6693
Eloxx Pharmaceuticals, Inc. (ELOX)Director58
Niagen Bioscience, Inc. (NAGE)Director33
Cocrystal Pharma, Inc. (COCP)Director22

Form 4 filings — Rubin Steven D

FiledFormIssuerReported transactionsSource
2026-08-074Entera Bio Ltd.Grant/award (A): 19,117 @ $0 · Grant/award (A): 33,368 (derivative) @ $0 · Grant/award (A): 43,405 (derivative) @ $0EDGAR
2026-07-284OPKO HEALTH, INC. (OPK)Tax withholding (F): 53,266 @ $1.22EDGAR
2026-06-264Niagen Bioscience, Inc. (NAGE)Grant/award (A): 31,746 (derivative) @ $0EDGAR
2026-06-104Eloxx Pharmaceuticals, Inc. (ELOX)Grant/award (A): 4,018 (derivative) @ $0EDGAR
2026-06-054Red Violet, Inc. (RDVT)Grant/award (A): 2,179EDGAR
2026-05-084Eloxx Pharmaceuticals, Inc. (ELOX)Option exercise (M): 1,875 · Grant/award (A): 179,854 (derivative) @ $0 · Option exercise (M): 1,875 (derivative) @ $0EDGAR
2026-02-174Entera Bio Ltd.Purchase (P): 5,000 @ $1.49EDGAR
2026-02-114Entera Bio Ltd.Purchase (P): 10,000 @ $1.20EDGAR
2026-01-134Cocrystal Pharma, Inc. (COCP)Grant/award (A): 16,410 (derivative) @ $0EDGAR
2025-12-224Red Violet, Inc. (RDVT)Grant/award (A): 4,450EDGAR
2025-06-254Niagen Bioscience, Inc. (NAGE)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2025-05-294OPKO HEALTH, INC. (OPK)Grant/award (A): 437,500 (derivative) @ $0EDGAR
2025-03-214Red Violet, Inc. (RDVT)Sale (S): 10,000 @ $38.93EDGAR
2025-01-284Eloxx Pharmaceuticals, Inc. (ELOX)Option exercise (M): 3,750 @ $0 · Option exercise (M): 3,750 (derivative) @ $0EDGAR
2024-11-054Red Violet, Inc. (RDVT)Grant/award (A): 8,000EDGAR
2024-10-174Eloxx Pharmaceuticals, Inc. (ELOX)Grant/award (A): 12,000 @ $0EDGAR
2024-10-114Cocrystal Pharma, Inc. (COCP)Grant/award (A): 18,957EDGAR
2024-07-264OPKO HEALTH, INC. (OPK)Grant/award (A): 437,500 @ $0EDGAR
2024-06-244ChromaDex Corp. (CDXC)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2024-01-264Eloxx Pharmaceuticals, Inc. (ELOX)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2024-01-054OPKO HEALTH, INC. (OPK)Purchase (P): 10,000 @ $0.87EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-04 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1381874 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →